SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
GENETIC TECHNOLOGIES LTD
(NQSC:GENE Last Sale: 2.04 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (GENE : $2.04)
$15,913 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today
60-66 Hanover Street, Fitzroy Research Report Earnings Snapshot - Last
Victoria, 3065 Annual Reports
Australia
Phone: 011-61-3-9415-1135

Mervyn Jacobson, Founder, Paul D. R. MacLeman, CEO, Thomas G. Howit, CFO
Received US approval for launch of BREVAGen breast cancer risk test April 27, 2011. Developed BREVAGen, a diagnostic test that informs clinicians and patients about individual, non-familial, sporadic risk of breast cancer for women where a breast biopsy outcome is indeterminate. Provides genetic testing services to humans for disease susceptibility, parentage, individual identity, forensics, and sports performance; animals, such as dogs, horses, birds, alpacas, exotics, and zoo animals for parentage, pedigree, traits, and disease susceptibility; and plants for traits and disease susceptibility. Also offers canine reproductive services and non-coding DNA patents. August 24, 2010 received a letter of non-compliance with Nasdaq's minimum bid price requirement of $1.00 per share. ADR=30 Ordinary shares.
Historical Charts    Technical Analysis
No Historical Data available for GENE

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common GENE $2.04 $2.04 0 .0 $1.96 $2.08 394,980 $1.96 $2.08 7,800,464
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $15,912,947

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
02-SEP-05 GNTLY Symbol Changed to GENE

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex